[Management of the patient with mucoviscidosis].
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001945:Breathing Exercises; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D003850:Deoxyribonuclease I / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011552:Pseudomonas Infections / Q000188:drug therapy; D011994:Recombinant Proteins / Q000627:therapeutic use; D012138:Respiratory Therapy; D013203:Staphylococcal Infections / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D011994:Recombinant Proteins; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I